These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28634046)

  • 21. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
    De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
    Zheng L; Jiao W; Mei H; Song H; Li D; Xiang X; Chen Y; Yang F; Li H; Huang K; Tong Q
    Oncotarget; 2016 Jun; 7(26):40314-40328. PubMed ID: 27259238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.
    Mudduluru G; Vajkoczy P; Allgayer H
    Mol Cancer Res; 2010 Feb; 8(2):159-69. PubMed ID: 20145042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
    Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis.
    Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN
    Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
    Vishwamitra D; Curry CV; Alkan S; Song YH; Gallick GE; Kaseb AO; Shi P; Amin HM
    Mol Cancer; 2015 Feb; 14():53. PubMed ID: 25884514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
    Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
    Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRAME expression and promoter hypomethylation in epithelial ovarian cancer.
    Zhang W; Barger CJ; Eng KH; Klinkebiel D; Link PA; Omilian A; Bshara W; Odunsi K; Karpf AR
    Oncotarget; 2016 Jul; 7(29):45352-45369. PubMed ID: 27322684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
    Nagasawa T; Zhang Q; Raghunath PN; Wong HY; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook AH; Vonderheid EC; Odum N; Wasik MA
    Leuk Res; 2006 Mar; 30(3):303-12. PubMed ID: 16185764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.
    Epping MT; Wang L; Edel MJ; Carlée L; Hernandez M; Bernards R
    Cell; 2005 Sep; 122(6):835-47. PubMed ID: 16179254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia.
    Steinbach D; Pfaffendorf N; Wittig S; Gruhn B
    Cancer Genet Cytogenet; 2007 Aug; 177(1):51-4. PubMed ID: 17693191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.
    Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA
    Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAX4 has the potential to function as a tumor suppressor in human melanoma.
    Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
    Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.